未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3-4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination异源新型冠状病毒肺炎加强疫苗在健康成人中接种两剂CoronaVac疫苗后3-4个月对Omicron BA.1,BA.2和BA.4/5变体的免疫原性和持久性
Assawakosri, Suvichada; Kanokudom, Sitthichai; Suntronwong, Nungruthai; Chansaenroj, Jira; Auphimai, Chompoonut; Nilyanimit, Pornjarim; Vichaiwattana, Preeyaporn; Thongmee, Thanunrat; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Klinfueng, Sirapa; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Mongkolsapaya, Juthathip; Honsawek, Sittisak; Poovorawan, Yong
分享
收藏Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year
Kanokudom, Sitthichai; Chansaenroj, Jira; Assawakosri, Suvichada; Suntronwong, Nungruthai; Yorsaeng, Ritthideach; Wongsrisang, Lakkhana; Aeemjinda, Ratchadawan; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Thatsanathorn, Thaksaporn; Honsawek, Sittisak; Poovorawan, Yong
分享
收藏
分享
收藏
分享
收藏The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.512种不同的三剂量方案后的第四剂mRNA新型冠状病毒肺炎疫苗: 对Omicron BA.4/BA.5的安全性和免疫原性
Kanokudom, Sitthichai; Chansaenroj, Jira; Suntronwong, Nungruthai; Assawakosri, Suvichada; Yorsaeng, Ritthideach; Nilyanimit, Pornjarim; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Thongmee, Thanunrat; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Honsawek, Sittisak; Poovorawan, Yong
分享
收藏
分享
收藏
分享
收藏
分享
收藏